| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/28/1995 | EP0659737A2 Catecholamine surrogates useful as B3 agonists |
| 06/28/1995 | EP0659428A1 2-Phenyl-3-azoylbenzothiophenes for treating obsessive-compulsive and consumptive disorders |
| 06/28/1995 | EP0659423A1 2-Phenyl-3-azoylbenzothiophenes for inhibiting weight gain or inducing weight loss |
| 06/28/1995 | EP0659408A1 Use of R(+)alpha-lipoic acid, R-(-)dihydrolipoic and metabolites for the treatment of diabetes mellitus and its resulting disorders |
| 06/28/1995 | EP0659402A2 Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| 06/28/1995 | EP0659349A1 Treatment of diabetes by administration of myo-inositol |
| 06/28/1995 | EP0659213A1 Growth hormone antagonists |
| 06/28/1995 | EP0659182A1 Piperazine derivatives and salts thereof |
| 06/28/1995 | EP0659179A1 Benzo-fused lactams promote release of growth hormone |
| 06/28/1995 | EP0642350A4 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties. |
| 06/28/1995 | CN1104203A Lifibrol and its use |
| 06/27/1995 | US5428182 Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| 06/27/1995 | US5428112 Anticholesterol agents; foodstuff additives |
| 06/27/1995 | US5428028 Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor |
| 06/27/1995 | US5428019 Bombesin analogs |
| 06/27/1995 | US5428018 Phenylalanine analogs of bombesin |
| 06/27/1995 | US5427940 Engineered cells producing insulin in response to glucose |
| 06/27/1995 | CA2022956C Agglomerated psyllium husk containing edible acid |
| 06/27/1995 | CA1336066C Modulation of adenylate cyclase response |
| 06/23/1995 | CA2137431A1 Treatment of diabetes by administration of myo-inositol |
| 06/22/1995 | WO1995016707A1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY |
| 06/22/1995 | WO1995016672A1 Vitamin d amine and amide derivatives |
| 06/22/1995 | WO1995016661A1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them |
| 06/22/1995 | WO1995016659A1 Novel retinoid conjugate compounds and methods for treating skin aging |
| 06/22/1995 | WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 06/22/1995 | CA2178964A1 Novel retinoid conjugate compounds and methods for treating skin aging |
| 06/22/1995 | CA2178218A1 Analogues of hgh-rh (1-29)nh2 having antagonistic activity |
| 06/22/1995 | CA2178090A1 Vitamin d amine and amide derivatives |
| 06/22/1995 | CA2138508A1 Methods for inhibiting ldl oxidation and atherosclerosis |
| 06/22/1995 | CA2138458A1 Methods of inhibiting obsessive-compulsive and consumptive disorders |
| 06/22/1995 | CA2138455A1 Methods for inhibiting weight gain or inducing weight loss |
| 06/22/1995 | CA2138454A1 Methods of inhibiting imperfect tissue repair |
| 06/21/1995 | EP0658552A1 Process for the preparation of alpha-tocopherol derivatives |
| 06/21/1995 | EP0658550A2 Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds |
| 06/21/1995 | EP0658348A2 Aqueous solution inclusion complexes of benzothiophene compounds with cyclodextrins |
| 06/21/1995 | EP0658161A1 Substituted thiazolidinedione derivatives |
| 06/21/1995 | EP0658116A1 Methods useful in endotoxin prophylaxis and therapy |
| 06/21/1995 | EP0658110A1 Use of norastemizole for the treatment of allergic disorders |
| 06/21/1995 | EP0540588B1 A composition providing improved clearance of bioactive substances from the bloodstream |
| 06/21/1995 | EP0511970B1 Method for preparing an enzymatic hydrolyzate |
| 06/21/1995 | CN1103871A Bile acid sequestrant |
| 06/21/1995 | CN1103785A A calcium containing composition with high oral bioavailability, manufacturing method of such a composition, health food containing such a composition, and pharmaceutical composition containing such.. |
| 06/21/1995 | CN1103783A Method of lowering blood lipid levels |
| 06/21/1995 | CN1103781A Use of phenalkylamines |
| 06/20/1995 | US5426197 Antiinflammatory, antiallergy or antitumor agents |
| 06/20/1995 | US5426123 Method for lowering serum cholesterol with 1,1,2-triphenylbut-1-ene derivatives |
| 06/20/1995 | US5426122 Methods for reducing blood pressure with dimercaptosuccinic acid (DMSA) |
| 06/20/1995 | US5426103 Certain macrocyclic lactam derivatives |
| 06/16/1995 | CA2137119A1 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
| 06/16/1995 | CA2137049A1 Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds |
| 06/15/1995 | WO1995015979A1 Pretargeting methods and compounds |
| 06/15/1995 | WO1995015958A1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 06/15/1995 | WO1995015957A1 Chroman derivative |
| 06/15/1995 | WO1995015760A1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
| 06/15/1995 | WO1995009619A3 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 06/15/1995 | CA2178476A1 Pretargeting methods and compounds |
| 06/15/1995 | CA2137533A1 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
| 06/15/1995 | CA2137481A1 Process for the preparation of .alpha.-tocopherol derivatives |
| 06/14/1995 | EP0657458A1 Protein kinase C inhibitors |
| 06/14/1995 | EP0657162A1 Methods for lowering serum cholesterol |
| 06/14/1995 | EP0657029A1 Calcium receptor active molecules |
| 06/14/1995 | EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 06/14/1995 | EP0656784A1 Parathyroid hormone fragments and analogs |
| 06/14/1995 | EP0656782A1 Nutritional product for persons having a neurological injury |
| 06/14/1995 | CN1028866C Method for preparation of methylene bis-phosphonic acid derivatives |
| 06/13/1995 | US5424302 Process for the production of starch degradation products with a narrow molecular weight distribution |
| 06/13/1995 | US5424300 Method for treatment of chronic fatigue syndrome |
| 06/13/1995 | US5424185 Human high-affinity neurotransmitter uptake system |
| 06/13/1995 | CA1335924C Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus |
| 06/08/1995 | WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | WO1995013071A3 Treatment of immunoregulatory disorders |
| 06/08/1995 | CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/07/1995 | EP0655915A1 Use of angiotensin ii antagonists for the treatment of hyperlipidaeme |
| 06/07/1995 | EP0655907A1 Use of diacylolycerols for increasing the melanin content in melanocytes |
| 06/07/1995 | CN1103402A Substituted pyrroles |
| 06/07/1995 | CN1028759C Substituted thiacycloalkeno |2,3-b¨ pyridines, method of preparation, compositions and method of use |
| 06/07/1995 | CN1028754C Quinoline derivatives, their production and use |
| 06/06/1995 | US5422371 Contacting a cell with a fatty acid or fatty alcohol to prevent reduction of testosterone to 5a-dihydrotestosterone |
| 06/06/1995 | US5422365 Naphthalene compounds |
| 06/06/1995 | US5422359 α-aminoketone derivatives |
| 06/06/1995 | US5422352 Administering a thermogenically effective dose of ephedrine and caffeine to reduce weight in humans |
| 06/06/1995 | US5422341 Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 06/06/1995 | US5422101 Cholesterol lowering drink mix compositions |
| 06/06/1995 | CA2044795C Dermatological composition based on an aqueous phase |
| 06/06/1995 | CA1335802C O-glycosylated igf-1 |
| 06/06/1995 | CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease |
| 06/06/1995 | CA1335789C Fatty acid compositions |
| 06/01/1995 | WO1995014682A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 06/01/1995 | WO1995014670A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 06/01/1995 | WO1995014669A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 06/01/1995 | WO1995014666A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
| 06/01/1995 | WO1995014662A1 26,28-methylene-1alpha,25-dihydroxyvitamin d2 compounds |
| 06/01/1995 | WO1995014657A1 Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors |
| 06/01/1995 | WO1995014478A1 Purine compositions and methods for administration |
| 06/01/1995 | CA2176140A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
| 06/01/1995 | CA2175828A1 Purine compositions and methods for administration |
| 06/01/1995 | CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 05/31/1995 | EP0655461A1 Cyclic amino acid derivatives having ACE and NEP inhibiting activity |
| 05/31/1995 | EP0655070A1 Triantennary cluster glycosides, their preparation and use |
| 05/31/1995 | EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |